A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
for Ulcerative Colitis
Sites in Rochester +25 more locations
Sponsor: Spyre Therapeutics, Inc.
Sex: All·Age: 18 - 75
Code: NCT07012395·Phase 2·Recruiting·Listed Jun 2025